10-Q - CTS - Equibles

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For The Quarterly Period Ended March 31, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from to

Commission File Number: 1-4639

CTS CORPORATION

(Exact name of registrant as specified in its charter)

IN	35-0225010
(State or other jurisdiction of<br><br><br>incorporation or organization)	(IRS Employer<br><br><br>Identification Number)
4925 Indiana Avenue
---	---
Lisle IL	60532
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (630) 577-8800

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol(s)	Name of Each Exchange on Which Registered
Common stock, without par value	CTS	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 (a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of April 22, 2022: 32,088,422.

CTS CORPORATION AND SUBSIDIARIES

TABLE OF CONTENTS

			Page
PART I. FINANCIAL INFORMATION
	Item 1.	Financial Statements	3
		Condensed Consolidated Statements of Earnings (Unaudited) For the Three Months Ended March 31, 2022 and March 31, 2021	3
		Condensed Consolidated Statements of Comprehensive Earnings (Unaudited) For the Three Months Ended March 31, 2022 and March 31, 2021	4
		Condensed Consolidated Balance Sheets As of March 31, 2022 (Unaudited) and December 31, 2021	5
		Condensed Consolidated Statements of Cash Flows (Unaudited) For the Three Months Ended March 31, 2022 and March 31, 2021	6
		Condensed Consolidated Statements of Shareholders’ Equity (Unaudited) For the Three Months Ended March 31, 2022 and March 31, 2021	7
		Notes to Condensed Consolidated Financial Statements ‑ (Unaudited)	9
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
	Item 3.	Quantitative and Qualitative Disclosures about Market Risk	28
	Item 4.	Controls and Procedures	29
PART II. OTHER INFORMATION
	Item 1.	Legal Proceedings	29
	Item 1A.	Risk Factors	29
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	30
	Item 6.	Exhibits	31
SIGNATURES			32

Item 1. Financial Statements

CTS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS - UNAUDITED

(In thousands of dollars, except per share amounts)

	Three Months Ended
	March 31,			March 31,
	2022			2021
Net sales	$	147,695		$	128,427
Cost of goods sold		93,355			85,836
Gross margin		54,340			42,591
Selling, general and administrative expenses		21,788			18,325
Research and development expenses		6,194			5,687
Restructuring charges		312			81
Operating earnings		26,046			18,498
Other (expense) income:
Interest expense		(546	)		(555	)
Interest income		180			202
Other income (expense), net		66			(3,356	)
Total other expense, net		(300	)		(3,709	)
Earnings before income taxes		25,746			14,789
Income tax expense		5,507			2,799
Net earnings	$	20,239		$	11,990
Earnings per share:
Basic	$	0.63		$	0.37
Diluted	$	0.63		$	0.37
Basic weighted – average common shares outstanding:		32,123			32,319
Effect of dilutive securities		204			301
Diluted weighted – average common shares outstanding:		32,327			32,620
Cash dividends declared per share	$	0.04		$	0.04

See notes to unaudited condensed consolidated financial statements.

CTS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS ‑ UNAUDITED

(In thousands of dollars)

	Three Months Ended
	March 31,			March 31,
	2022			2021
Net earnings	$	20,239		$	11,990
Other comprehensive earnings (loss):
Changes in fair market value of derivatives, net of tax		1,235			124
Changes in unrealized pension cost, net of tax		94			1,422
Cumulative translation adjustment, net of tax		(249	)		12
Other comprehensive earnings	$	1,080		$	1,558
Comprehensive earnings	$	21,319		$	13,548

See notes to unaudited condensed consolidated financial statements.

CTS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands of dollars)

	(Unaudited)
	March 31,			December 31,
	2022			2021
ASSETS
Current Assets
Cash and cash equivalents	$	126,118		$	141,465
Accounts receivable, net		95,107			82,191
Inventories, net		52,454			49,506
Other current assets		18,366			15,927
Total current assets		292,045			289,089
Property, plant and equipment, net		97,041			96,876
Operating lease assets, net		23,212			21,594
Other Assets
Prepaid pension asset		31,882			49,382
Goodwill		117,524			109,798
Other intangible assets, net		79,849			69,888
Deferred income taxes		23,828			25,415
Other		19,365			2,420
Total other assets		272,448			256,903
Total Assets	$	684,746		$	664,462
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities
Accounts payable	$	60,010		$	55,537
Operating lease obligations		3,522			3,393
Accrued payroll and benefits		12,954			18,418
Accrued expenses and other liabilities		38,554			36,718
Total current liabilities		115,040			114,066
Long-term debt		50,000			50,000
Long-term operating lease obligations		22,712			21,354
Long-term pension obligations		6,464			6,886
Deferred income taxes		5,865			5,894
Other long-term obligations		4,487			2,684
Total Liabilities		204,568			200,884
Commitments and Contingencies (Note 11)
Shareholders’ Equity
Common stock		316,496			314,620
Additional contributed capital		41,158			42,549
Retained earnings		511,197			492,242
Accumulated other comprehensive loss		(3,445	)		(4,525	)
Total shareholders’ equity before treasury stock		865,406			844,886
Treasury stock		(385,228	)		(381,308	)
Total shareholders’ equity		480,178			463,578
Total Liabilities and Shareholders’ Equity	$	684,746		$	664,462

See notes to unaudited condensed consolidated financial statements.

CTS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS ‑ UNAUDITED

(In thousands of dollars)

	Three Months Ended
	March 31,			March 31,
	2022			2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net earnings	$	20,239		$	11,990
Adjustments to reconcile net earnings to net cash provided by operating<br><br><br>activities:
Depreciation and amortization		6,749			6,800
Pension and other post-retirement plan expense		91			1,980
Stock-based compensation		1,950			1,219
Deferred income taxes		1,195			63
Gain on foreign currency hedges, net of cash		(15	)		(42	)
Changes in assets and liabilities, net of acquisition:
Accounts receivable		(9,969	)		(1,121	)
Inventories		(615	)		(2,052	)
Operating lease assets		(224	)		(340	)
Other assets		(253	)		168
Accounts payable		3,936			2,864
Accrued payroll and benefits		(5,733	)		(210	)
Operating lease liabilities		93			325
Accrued expenses and other liabilities		2,219			(1,398	)
Pension and other post-retirement plans		(377	)		(136	)
Net cash provided by operating activities		19,286			20,110
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures		(3,400	)		(1,638	)
Payments for acquisition, net of cash received		(24,484	)		—
Net cash used in investing activities		(27,884	)		(1,638	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments of long-term debt		(150,000	)		(241,600	)
Proceeds from borrowings of long-term debt		150,000			237,000
Purchase of treasury stock		(3,920	)		—
Dividends paid		(1,289	)		(1,291	)
Payment of contingent consideration		(150	)		—
Taxes paid on behalf of equity award participants		(1,413	)		(1,402	)
Net cash used in financing activities		(6,772	)		(7,293	)
Effect of exchange rate changes on cash and cash equivalents		23			440
Net (decrease) increase in cash and cash equivalents		(15,347	)		11,619
Cash and cash equivalents at beginning of period		141,465			91,773
Cash and cash equivalents at end of period	$	126,118		$	103,392
Supplemental cash flow information:
Cash paid for interest	$	480		$	378
Cash paid for income taxes, net	$	2,548		$	3,510
Non-cash financing and investing activities:
Capital expenditures incurred but not paid	$	1,339		$	1,019

See notes to unaudited condensed consolidated financial statements.

CTS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - UNAUDITED

(in thousands of dollars)

The following summarizes the changes in total equity for the three months ended March 31, 2022:

		Additional<br><br><br>Contributed<br><br><br>Capital			Retained<br><br><br>Earnings			Accumulated<br><br><br>Other<br><br><br>Comprehensive<br><br><br>Loss			Treasury<br><br><br>Stock			Total
Balances at December 31, 2021	314,620	$	42,549		$	492,242		$	(4,525	)	$	(381,308	)	$	463,578
Net earnings	—		—			20,239			—			—			20,239
Changes in fair market value of derivatives, net of tax	—		—			—			1,235			—			1,235
Changes in unrealized pension cost, net of tax	—		—			—			94			—			94
Cumulative translation adjustment, net of tax	—		—			—			(249	)		—			(249	)
Cash dividends of 0.04 per share	—		—			(1,284	)		—			—			(1,284	)
Acquired 116,176 shares of treasury stock	—		—			—			—			(3,920	)		(3,920	)
Issued shares on vesting of restricted stock units	1,876		(3,289	)		—			—			—			(1,413	)
Stock compensation	—		1,898			—			—			—			1,898
Balances at March 31, 2022	316,496	$	41,158		$	511,197		$	(3,445	)	$	(385,228	)	$	480,178

All values are in US Dollars.

See notes to unaudited condensed consolidated financial statements.

CTS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - UNAUDITED

(in thousands of dollars)

The following summarizes the changes in total equity for the three months ended March 31, 2021:

		Additional<br><br><br>Contributed<br><br><br>Capital			Retained<br><br><br>Earnings			Accumulated<br><br><br>Other<br><br><br>Comprehensive<br><br><br>Loss			Treasury<br><br><br>Stock			Total
Balances at December 31, 2020	311,190	$	41,654		$	539,281		$	(95,921	)	$	(372,522	)	$	423,682
Net earnings	—		—			11,990			—			—			11,990
Changes in fair market value of derivatives, net of tax	—		—			—			124			—			124
Changes in unrealized pension cost, net of tax	—		—			—			1,422			—			1,422
Cumulative translation adjustment, net of tax	—		—			—			12			—			12
Cash dividends of 0.04 per share	—		—			(1,294	)		—			—			(1,294	)
Issued shares on vesting of restricted stock units	1,818		(3,218	)		—			—			—			(1,400	)
Stock compensation	—		1,180			—			—			—			1,180
Balances at March 31, 2021	313,008	$	39,616		$	549,977		$	(94,363	)	$	(372,522	)	$	435,716

All values are in US Dollars.

See notes to unaudited condensed consolidated financial statements.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

(in thousands except for share and per share data)

March 31, 2022

NOTE 1 — Basis of Presentation

The accompanying condensed consolidated financial statements have been prepared by CTS Corporation (“CTS”, "we", "our", "us" or the "Company”), without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been omitted pursuant to such rules and regulations. The unaudited condensed consolidated financial statements should be read in conjunction with the financial statements, notes thereto, and other information included in the Company’s Annual Report on Form 10‑K for the year ended December 31, 2021.

The accompanying unaudited condensed consolidated financial statements reflect, in the opinion of management, all adjustments (consisting of normal recurring items) necessary for a fair statement, in all material respects, of the financial position and results of operations for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ materially from those estimates. The results of operations for the interim periods are not necessarily indicative of the results for the entire year. Certain reclassifications have been made to prior year amounts to conform to the current year presentation. The reclassifications had no impact on previously reported net earnings.

There have been no material changes in the Company’s significant accounting policies as compared to the significant accounting policies described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.

NOTE 2 – Revenue Recognition

The core principle of Accounting Standard Codification (“ASC”) Topic 606 Revenue from Contracts with Customers is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance provides a five-step process to achieve that core principle:

•	Identify the contract(s) with a customer
•	Identify the performance obligations
---	---
•	Determine the transaction price
---	---
•	Allocate the transaction price
---	---
•	Recognize revenue when the performance obligations are met
---	---

We recognize revenue when the performance obligations specified in our contracts have been satisfied, after considering the impact of variable consideration and other factors that may affect the transaction price. Our contracts normally contain a single performance obligation that is fulfilled on the date of delivery or shipment based on shipping terms stipulated in the contract. We usually expect payment within 30 to 90 days from the shipping date, depending on our terms with the customer. None of our contracts as of March 31, 2022 contained a significant financing component. Differences between the amount of revenue recognized and the amount invoiced, collected from, or paid to our customers are recognized as contract assets or liabilities. Contract assets will be reviewed for impairment when events or circumstances indicate that they may not be recoverable.

To the extent the transaction price includes variable consideration, we estimate the amount of variable consideration that should be included in the transaction price utilizing the most likely amount method based on an analysis of historical experience and current facts and circumstances, which requires significant judgment. Variable consideration is included in the transaction price if, in our judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur.

Disaggregated Revenue

The following table presents revenues disaggregated by the major markets we serve:

	Three months ended
	March 31, 2022		March 31, 2021
Transportation	$	79,134	$	75,854
Industrial		40,007		29,627
Medical		15,867		11,276
Aerospace & Defense		12,687		11,670
Total	$	147,695	$	128,427

NOTE 3 – Business Acquisitions

TEWA Temperature Sensors SP. Zo.o. Acquisition

On February 28, 2022, we acquired 100% of the outstanding shares of TEWA Temperature Sensors SP. Zo.o. (“TEWA”). TEWA is a designer and manufacturer of high-quality temperature sensors. TEWA has complementary capabilities with our existing temperature sensing platform and the acquisition supports our end market diversification strategy by expanding our presence in Europe.

The purchase price, which includes assumed changes in working capital, of $24,484, net of cash acquired of $2,945, has been allocated to the fair values of assets and liabilities acquired as of February 28, 2022. The allocation of the purchase price continues to be preliminary pending the completion of the valuation of intangible assets and finalization of management's estimates. The final purchase price allocation may result in a materially different allocation than that recorded as of March 31, 2022.

The following table summarizes the consideration paid and the fair values of the assets acquired, and the liabilities assumed as of the date of acquisition:

	Fair Values at<br><br><br>February 28, 2022
Current assets	$	6,702
Property, plant and equipment		2,175
Other assets		28
Goodwill		7,726
Intangible assets		12,348
Fair value of assets acquired		28,979
Less fair value of liabilities acquired		(4,495	)
Purchase price	$	24,484

Goodwill represents value the Company expects to be created by combining the operations of the acquired business with the Company's operations, including the expansion of customer relationships, access to new customers, and potential cost savings and synergies. Goodwill related to the acquisition is expected to be deductible for tax purposes.

The Company recorded a $1,164 step-up of inventory to its fair value as of the acquisition date based on the preliminary valuation. The step-up is being amortized as a non-cash charge to cost of goods sold as the acquired inventory was sold with $580 recognized in the first quarter of 2022.

Intangible assets acquired have been assigned a provisional value of $12,348 and an estimated weighted average amortization period of 12 years. They are included as customer lists/relationships in our Condensed Consolidated Balance Sheets and subsequent notes. Due to the timing of the acquisition, the identification and valuation of all intangible assets remains incomplete; however, management used historical experience and projections to estimate the potential value at March 31, 2022. The amount and assumptions included above remain an estimate that will be adjusted once purchase accounting is complete.

Ferroperm Piezoceramics A/S Announced Acquisition

On April 12, 2022, we entered into a Share Sale and Purchase Agreement (“SPA”) with Meggitt International, Ltd., a private limited company incorporated in England and Wales (“Seller”), and Meggitt International Holdings, Ltd., a private limited company incorporated in England and Wales (“Guarantor”), to acquire (the “Ferroperm Acquisition”) Meggitt A/S (a/k/a Ferroperm Piezoceramics A/S), a company incorporated in Denmark (“Ferroperm”). Seller and Guarantor are wholly-owned subsidiaries of Meggitt PLC, a public limited company incorporated in England and Wales. Ferroperm is a wholly-owned subsidiary of Seller, and a leading provider of advanced materials focused on high performance piezoelectric ceramics with a majority of its sales in the medical end-market.

Pursuant to the SPA, the Company has agreed to purchase all of the issued and outstanding shares of Ferroperm from Seller for DKK 525 million in cash (approximately $76,800 based on the exchange rate between DKK and USD of 6.836 as of April 12, 2022), subject to customary net debt and working capital adjustments. The Ferroperm Acquisition is subject to the receipt of certain governmental approvals and the satisfaction of other closing conditions. The SPA contains customary conditions, representations, warranties, indemnities and covenants by, among, and for the benefit of the parties. At the time of the SPA, we hedged approximately DKK 400 million of the purchase price in order to manage the Company’s foreign currency risk. The hedge does not qualify for hedge accounting.

NOTE 4 – Accounts Receivable, net

The components of accounts receivable, net are as follows:

	As of
	March 31,			December 31,
	2022			2021
Accounts receivable, gross	$	96,499		$	83,848
Less: Allowance for credit losses		(1,392	)		(1,657	)
Accounts receivable, net	$	95,107		$	82,191

NOTE 5 – Inventories, net

Inventories, net consists of the following:

	As of
	March 31,			December 31,
	2022			2021
Finished goods	$	10,891		$	11,955
Work-in-process		19,525			18,878
Raw materials		31,032			28,078
Less: Inventory reserves		(8,994	)		(9,405	)
Inventories, net	$	52,454		$	49,506

NOTE 6 – Property, Plant and Equipment, net

Property, plant and equipment, net is comprised of the following:

	As of
	March 31,			December 31,
	2022			2021
Land and land improvements	$	1,099		$	1,095
Buildings and improvements		71,176			69,614
Machinery and equipment		247,174			247,708
Less: Accumulated depreciation		(222,408	)		(221,541	)
Property, plant and equipment, net	$	97,041		$	96,876

Depreciation expense for the three months ended March 31, 2022 and March 31, 2021 was $4,368 and $4,431, respectively.

NOTE 7 – Retirement Plans

Pension Plans

Net pension expense for our domestic and foreign plans included in other income (expense), net in the Condensed Consolidated Statement of Earnings is as follows:

	Three months ended
	March 31,		March 31,
	2022		2021
Net pension expense	$	65	$	1,957

The components of net pension expense for our domestic and foreign plans include the following:

	Domestic Pension Plans					Foreign Pension Plans
	Three Months Ended					Three Months Ended
	March 31,		March 31,			March 31,			March 31,
	2022		2021			2022			2021
Service cost	$	—	$	—		$	6		$	6
Interest cost		5		1,253			4			4
Expected return on plan assets^(1)^		—		(1,113	)		(3	)		(3	)
Amortization of loss		8		1,767			45			43
Total expense, net	$	13	$	1,907		$	52		$	50
(1)	Expected return on plan assets is net of expected investment expenses and certain administrative expenses.
---	---

In February 2020, the CTS Board of Directors authorized management to explore termination of the U.S.-based pension plan ("Plan"), subject to certain conditions. On June 1, 2020, we entered into the Fifth Amendment to the Plan whereby we set an effective termination date for the Plan of July 31, 2020. In February 2021, we received a determination letter from the Internal Revenue Service that allowed us to proceed with the termination process for the Plan. During the second quarter of 2021, the Company offered the option of receiving a lump sum payment to eligible participants with vested qualified Plan benefits in lieu of receiving monthly annuity payments. Approximately 365 participants elected to receive the settlement, and lump sum payments of approximately $35,594 were made from Plan assets to these participants in June 2021.

As required under U.S. GAAP, the Company recognizes a settlement gain or loss when the aggregate amount of lump-sum distributions to participants equals or exceeds the sum of the service and interest cost components of the net periodic pension cost. The amount of settlement gain or loss recognized is the pro rata amount of the existing unrealized gain or loss immediately prior to the settlement. In general, both the projected benefit obligation and fair value of plan assets are required to be remeasured in order to determine the settlement gain or loss.

Upon the partial settlement of the pension liability due to the lump sum offering in the second quarter of 2021, the Company recognized a non-cash and non-operating settlement charge of $20,063 related to pension losses, reclassified from accumulated other comprehensive loss to other income (expense) in the Company's Condensed Consolidated Statements of Earnings.

On July 29, 2021, the Plan purchased a group annuity contract that transferred our benefit obligations for approximately 2,700 CTS participants and beneficiaries in the United States (“Transferred Participants”). As part of the purchase of the group annuity contract, Plan benefit obligations and related annuity administration services for Transferred Participants were irrevocably assumed and guaranteed by the insurance company effective as of August 3, 2021. There will be no change to pension benefits for Transferred Participants. The purchase of the group annuity contract was fully funded directly by Plan assets.

As a result of the final settlement of the pension liability with the purchase of annuities, we reclassified the remaining related unrecognized pension losses of $106,206 that were previously recorded in accumulated other comprehensive loss to the Consolidated Statements of Earnings as a non-cash and non-operating settlement charge in the third quarter of 2021.

In January 2022, we transferred approximately $17,500 of funds from Plan assets to a qualified replacement plan (“QRP”) managed by the Company. The QRP requires that these assets be used to fund future annual Company contributions to our U.S. 401(k) program. The Plan assets of $31,882 as of March 31, 2022, will remain in the Plan until final administrative tasks are completed. This

process is expected to be completed in the second quarter of 2022, whereby the remaining Plan assets will liquidate and revert to CTS. At that time, the funds will be subject to income and excise taxes.

	As of
	March 31, 2022
	Gross<br><br><br>Carrying<br><br><br>Amount		Accumulated<br><br><br>Amortization			Net Amount
Customer lists/relationships	$	109,237	$	(50,676	)	$	58,561
Technology and other intangibles		47,441		(26,153	)		21,288
Other intangible assets, net	$	156,678	$	(76,829	)	$	79,849
Amortization expense for the three months ended March 31, 2022			$	2,381
	As of
---	---	---	---	---	---	---	---
	December 31, 2021
	Gross<br><br><br>Carrying<br><br><br>Amount		Accumulated<br><br><br>Amortization			Net Amount
Customer lists/relationships	$	96,889	$	(49,213	)	$	47,676
Technology and other intangibles		47,441		(25,229	)		22,212
Other intangible assets, net	$	144,330	$	(74,442	)	$	69,888
Amortization expense for the three months ended March 31, 2021			$	2,369

	Amortization<br><br><br>expense
2022	$	7,581
2023		8,149
2024		7,987
2025		7,765
2026		7,731
Thereafter		40,636
Total amortization expense	$	79,849

	Total
Goodwill as of December 31, 2021	$	109,798
Increase from acquisition		7,726
Goodwill as of March 31, 2022		117,524

Restructuring liability at January 1, 2022	$	962
Restructuring charges		312
Cost paid		(458	)
Other activity^(1)^		—
Restructuring liability at March 31, 2022	$	816
(1)	Other activity includes the effects of currency translation, non-cash asset write-downs and other charges that do not flow through restructuring expense.
---	---

	As of
	March 31,		December 31,
	2022		2021
Interest rate swaps reported in Other current assets	$	43	$	—
Interest rate swaps reported in Other assets	$	262	$	—
Interest rate swaps reported in Accrued expenses and other liabilities	$	—	$	(437	)
Interest rate swaps reported in Other long-term obligations	$	—	$	(353	)
Foreign currency hedges reported in Other current assets	$	660	$	135

The Company has elected to net its foreign currency derivative assets and liabilities in the balance sheet in accordance with ASC 210-20 (Balance Sheet, Offsetting). On a gross basis, there were foreign currency derivative assets of $660 and foreign currency derivative liabilities of $0 at March 31, 2022.

The effect of derivative instruments on the Condensed Consolidated Statements of Earnings is as follows:

	Three Months Ended
	March 31,		March 31,
	2022		2021
Foreign Exchange Contracts:
Amounts reclassified from AOCI to earnings:
Cost of goods sold	$	146	$	221
Selling, general and administrative expense		—		—
Total gain reclassified from AOCI to earnings		146		221
Total derivative gain on foreign exchange contracts recognized in earnings	$	146	$	221
Interest Rate Swaps:
Benefit (expense) recorded in Interest expense	$	171	$	(176	)
Total net gains on derivatives	$	317	$	45

NOTE 14 – Accumulated Other Comprehensive Loss

Shareholders’ equity includes certain items classified as accumulated other comprehensive loss (“AOCI”) in the Condensed Consolidated Balance Sheets, including:

•	Unrealized gains (losses) on hedges relate to interest rate swaps to convert a portion of our Revolving Credit Facility's outstanding balance from a variable rate of interest into a fixed rate and foreign currency forward contracts used to hedge our exposure to changes in exchange rates affecting certain revenues and costs denominated in foreign currencies. These hedges are designated as cash flow hedges, and we have deferred income statement recognition of gains and losses until the hedged transactions occur, at which time amounts are reclassified into earnings. Further information related to our derivative financial instruments is included in Note 13 - Derivative Financial Instruments and Note 17 – Fair Value Measurements.
•	Unrealized gains (losses) on pension obligations are deferred from income statement recognition until the gains or losses are realized. Amounts reclassified to income from AOCI are included in net periodic pension income (expense). Further information related to our pension obligations is included in Note 7 – Retirement Plans.
---	---
•	Cumulative translation adjustments relate to our non-U.S. subsidiary companies that have designated a functional currency other than the U.S. Dollar. We are required to translate the subsidiary functional currency financial statements to dollars using a combination of historical, period-end, and average foreign exchange rates. This combination of rates creates the foreign currency translation adjustment component of other comprehensive income.
---	---

Changes in exchange rates between the functional currency and the currency in which a transaction is denominated are foreign exchange transaction gains or losses. Transaction losses for the three months ended March 31, 2022 and March 31, 2021 were $288 and $1,330, respectively, which have been included in other income (expense) in the Condensed Consolidated Statements of Earnings.

The components of accumulated other comprehensive loss for the three months ended March 31, 2022 are as follows:

							(Gain) Loss
	As of			Gain (Loss)			Reclassified			As of
	December 31,			Recognized			from AOCI			March 31,
	2021			in OCI			to Earnings			2022
Changes in fair market value of derivatives:
Gross	$	(634	)	$	1,577		$	26		$	969
Income tax benefit (expense)		147			(363	)		(5	)		(221	)
Net		(487	)		1,214			21			748
Changes in unrealized pension cost:
Gross		(2,744	)		—			120			(2,624	)
Income tax benefit (expense)		738			—			(26	)		712
Net		(2,006	)		—			94			(1,912	)
Cumulative translation adjustment:
Gross		(2,032	)		(249	)		—			(2,281	)
Income tax benefit		—			—			—			—
Net		(2,032	)		(249	)		—			(2,281	)
Total accumulated other comprehensive (loss) income	$	(4,525	)	$	965		$	115		$	(3,445	)

The components of accumulated other comprehensive loss for the three months ended March 31, 2021, are as follows:

							(Gain) Loss
	As of			(Loss) Gain			Reclassified			As of
	December 31,			Recognized			from AOCI			March 31,
	2020			in OCI			to Earnings			2021
Changes in fair market value of derivatives:
Gross	$	(1,038	)	$	206		$	(45	)	$	(877	)
Income tax benefit (expense)		240			(47	)		10			203
Net		(798	)		159			(35	)		(674	)
Changes in unrealized pension cost:
Gross		(128,004	)		—			1,847			(126,157	)
Income tax benefit (expense)		34,917			—			(425	)		34,492
Net		(93,087	)		—			1,422			(91,665	)
Cumulative translation adjustment:
Gross		(2,036	)		12			—			(2,024	)
Income tax benefit (expense)		—			—			—			—
Net		(2,036	)		12			—			(2,024	)
Total accumulated other comprehensive (loss) income	$	(95,921	)	$	171		$	1,387		$	(94,363	)

NOTE 15 – Shareholders’ Equity

Share count and par value data related to shareholders’ equity are as follows:

	As of
	March 31,		December 31,
	2022		2021
Preferred Stock
Par value per share	No par value		No par value
Shares authorized		25,000,000		25,000,000
Shares outstanding		—		—
Common Stock
Par value per share	No par value		No par value
Shares authorized		75,000,000		75,000,000
Shares issued		57,305,743		57,245,060
Shares outstanding		32,123,222		32,178,715
Treasury stock
Shares held		25,182,521		25,066,345

On May 13, 2021, the Board of Directors approved a new share repurchase program that authorizes the Company to repurchase up to $50,000 of the Company’s common stock. The repurchase program has no set expiration date and replaces the repurchase program approved by the Board of Directors on February 7, 2019. During the three months ended March 31, 2022, 116,176 shares of common stock were repurchased for $3,920. During the three months ended March 31, 2021, there were no shares of common stock that were repurchased. As of March 31, 2022, approximately $37,295 remains available for future purchases.

A roll-forward of common shares outstanding is as follows:

	Three months ended
	March 31,			March 31,
	2022			2021
Balance at the beginning of the year		32,178,715			32,276,787
Repurchases		(116,176	)		—
Restricted share issuances		60,683			71,573
Balance at the end of the period		32,123,222			32,348,360

Certain potentially dilutive restricted stock units are excluded from diluted earnings per share because they are anti-dilutive. The number of outstanding awards that were anti-dilutive for the three months ended March 31, 2022 and 2021 were 38,384 and 35,167, respectively.

NOTE 16- Stock-Based Compensation

At March 31, 2022, we had five active stock-based compensation plans: the Non-Employee Directors’ Stock Retirement Plan (“Directors’ Plan”), the 2004 Omnibus Long-Term Incentive Plan (“2004 Plan”), the 2009 Omnibus Equity and Performance Incentive Plan (“2009 Plan”), the 2014 Performance and Incentive Compensation Plan (“2014 Plan”), and the 2018 Equity and Incentive Compensation Plan ("2018 Plan"). Future grants can only be made under the 2018 Plan.

These plans allow for grants of stock options, stock appreciation rights, restricted stock, restricted stock units ("RSUs"), performance shares, performance units, and other stock awards subject to the terms of the specific plans under which the awards are granted.

The following table summarizes the compensation expense included in selling, general and administrative expenses in the Condensed Consolidated Statements of Earnings related to stock-based compensation plans:

	Three months ended
	March 31,		March 31,
	2022		2021
Service-based RSUs	$	676	$	686
Performance-based RSUs		1,222		494
Cash-settled RSUs		52		39
Total	$	1,950	$	1,219
Income tax benefit		449		281
Net expense	$	1,501	$	938

The following table summarizes the unrecognized compensation expense related to non-vested RSUs by type and the weighted-average period in which the expense is to be recognized:

	Unrecognized
	Compensation		Weighted-
	Expense at		Average
	March 31, 2022		Period
Service-based RSUs	$	3,433		1.56
Performance-based RSUs		6,118		2.08
Total	$	9,551		1.89

We recognize expense on a straight-line basis over the requisite service period for each separately vesting portion of the award as if the award was, in substance, multiple awards.

The following table summarizes the status of these plans as of March 31, 2022:

					Directors'<br><br><br>Plan
Awards originally available	2,500,000	1,500,000	3,400,000	6,500,000	N/A
Maximum potential RSU and cash settled<br><br><br>awards outstanding	728,468	35,100	45,200	14,545		4,722
Maximum potential awards outstanding	728,468	35,100	45,200	14,545		4,722
RSUs and cash settled awards vested and released	110,669	—	—	—		—
Awards available for grant	1,660,863	—	—	—		—

Service-Based Restricted Stock Units

The following table summarizes the service-based RSU activity for the three months ended March 31, 2022:

			Weighted<br><br><br>Average<br><br><br>Grant Date<br><br><br>Fair Value
Outstanding at December 31, 2021	283,216		$	24.91
Granted	65,486			33.59
Vested and released	(51,485	)		30.69
Forfeited	(3,753	)		29.44
Outstanding at March 31, 2022	293,464		$	25.78
Releasable at March 31, 2022	132,667		$	17.53

Performance and Market-Based Restricted Stock Units

The following table summarizes the performance and market-based RSU activity for the three months ended March 31, 2022:

			Weighted<br><br><br>Average<br><br><br>Grant Date<br><br><br>Fair Value
Outstanding at December 31, 2021	237,767		$	31.33
Granted	79,202			37.17
Attained by performance	5,128			29.50
Released	(51,848	)		30.64
Forfeited	(9,653	)		30.84
Outstanding at March 31, 2022	260,596		$	33.23
Releasable at March 31, 2022	—		$	—

Cash-Settled Restricted Stock Units

Cash-Settled RSUs entitle the holder to receive the cash equivalent of one share of common stock for each unit when the unit vests. These RSUs are issued to key employees residing in foreign locations as direct compensation. Generally, these RSUs vest over a three-year period. Cash-Settled RSUs are classified as liabilities and are remeasured at each reporting date until settled. At March 31, 2022 and December 31, 2021 we had 44,430 and 32,085 cash-settled RSUs outstanding, respectively. At March 31, 2022 and December 31, 2021, liabilities of $212 and $400, respectively, were included in accrued expenses and other liabilities on our Condensed Consolidated Balance Sheets.

NOTE 17 — Fair Value Measurements

The table below summarizes our financial assets and liabilities that were measured at fair value on a recurring basis at March 31, 2022:

				Quoted<br><br><br>Prices<br><br><br>in Active
	Asset (Liability)					Significant
	Carrying			Markets for			Other		Significant
	Value at			Identical			Observable		Unobservable
	March 31,			Instruments			Inputs		Inputs
	2022			(Level 1)			(Level 2)		(Level 3)
Interest rate swaps	$	305		$	—		$	305	$	—
Foreign currency hedges	$	660		$	—		$	660	$	—
Contingent consideration	$	(1,050	)	$	—		$	—	$	(1,050	)
Qualified replacement plan assets	$	16,766		$	16,766		$	—	$	—

The table below summarizes the financial assets and liabilities that were measured at fair value on a recurring basis as of December 31, 2021:

				Quoted<br><br><br>Prices<br><br><br>in Active
	Asset (Liability)					Significant
	Carrying			Markets for			Other			Significant
	Value at			Identical			Observable			Unobservable
	December 31,			Instruments			Inputs			Inputs
	2021			(Level 1)			(Level 2)			(Level 3)
Interest rate swaps	$	(790	)	$	—		$	(790	)	$	—
Foreign currency hedges	$	135		$	—		$	135		$	—
Contingent consideration	$	(1,200	)	$	—		$	—		$	(1,200	)

We use interest rate swaps to convert a portion of our Revolving Credit Facility’s outstanding balance from a variable rate of interest into a fixed rate and foreign currency forward contracts to hedge the effect of foreign currency changes on certain revenues and costs denominated in foreign currencies. These derivative financial instruments are measured at fair value on a recurring basis. The fair value of our interest rate swaps and foreign currency hedges were measured using standard valuation models using market-based observable inputs over the contractual terms, including forward yield curves, among others. There is a readily determinable market for these derivative instruments, but that market is not active and therefore they are classified within Level 2 of the fair value hierarchy.

The fair value of the contingent consideration requires significant judgment. The Company's fair value estimates used in the contingent consideration valuation are considered Level 3 fair value measurements. The fair value estimates were based on assumptions management believes to be reasonable, but that are inherently uncertain, including estimates of future revenues and timing of events and activities that are expected to take place.

A roll-forward of the contingent consideration is as follows:

	Contingent
	Consideration
Balance at December 31, 2021	$	1,200
Settled in cash		(150	)
Balance at March 31, 2022 in accrued expenses and other liabilities	$	1,050

Our long-term debt consists of the Revolving Credit Facility which is recorded at its carrying value. There is a readily determinable market for our long-term debt and it is classified within Level 2 of the fair value hierarchy as the market is not deemed to be active. The fair value of long-term debt approximates carrying value and was determined by valuing a similar hypothetical coupon bond and attributing that value to our long-term debt under the Revolving Credit Facility.

The QRP assets consist of investment funds maintained for future contributions to the Company’s U.S. 401(k) program. See Note 7 for further information on the QRP. The investments are Level 1 marketable securities and are recorded in Other assets on our Condensed Consolidated Balance Sheets.

NOTE 18 — Income Taxes

The effective tax rates for the three months ended March 31, 2022 and 2021 are as follows:

	Three months ended
	March 31,			March 31,
	2022			2021
Effective tax rate		21.4	%		18.9	%

Our effective income tax rate was 21.4% and 18.9% in the first quarters of 2022 and 2021, respectively. The increase in effective income tax is primarily attributed to an increase in foreign withholding taxes. The first quarter 2022 effective income tax rate was higher than the U.S. statutory federal tax rate primarily due to the impact of foreign withholding taxes and state taxes. The first quarter 2021 effective tax rate was lower than the U.S. statutory federal tax rate primarily due to foreign earnings that are taxed at lower rates and tax benefits recorded upon vesting of restricted stock units.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”)

(in thousands of dollars, except percentages and per share amounts)

The following discussion should be read in conjunction with our unaudited Condensed Consolidated Financial Statements and notes included under Item 1, as well as our Consolidated Financial Statements and notes and related Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2021.

Overview

CTS Corporation ("CTS", "we", "our" or "us") is a leading designer and manufacturer of products that Sense, Connect and Move. Our vision is to be a leading provider of sensing and motion devices as well as connectivity components, enabling an intelligent and seamless world. These devices are categorized by their ability to Sense, Connect or Move. Sense products provide vital inputs to electronic systems. Connect products allow systems to function in synchronization with other systems. Move products ensure required movements are effectively and accurately executed. We are committed to achieving our vision by continuing to invest in the development of products and technologies, and talent within these categories.

We manufacture sensors, actuators, and connectivity components in North America, Europe, and Asia. CTS provides engineered products to original equipment manufacturers (“OEMs”) and tier one suppliers in the aerospace and defense, industrial, medical, and transportation markets.

There is an increasing proliferation of sensing, connectivity, and motion applications within various markets we serve. Our success is dependent on the ability to execute our strategy to support these trends. We are subject to challenges including, without limitation, periodic market softness, competition from other suppliers, changes in technology, and the ability to add new customers, launch new products or penetrate new markets.

COVID-19 Impact and Supply Chain Uncertainties

The COVID-19 pandemic and subsequent supply chain uncertainties have had a significant negative impact on the global economy in 2020, 2021, and into 2022. These events have disrupted the financial markets, negatively impacted the global supply chain and increased the cost of materials and operations, particularly within the global automotive industry. Key semiconductor chip and other critical part shortages continue to force OEMs to shut down production, often on short notice. With customers changing orders on short notice, we run the risk of carrying excess inventory in these situations. These developments are outside of our control, remain highly uncertain, and cannot be predicted. In addition, the supply chain shortages continue to put pressure on our manufacturing costs and our gross margins. We continue to actively monitor the ongoing impacts of the COVID-19 pandemic and supply chain issues and will seek to mitigate and minimize their impact on our business, when possible. We anticipate these challenges to continue to impact our results for the remainder of 2022 and we remain cautious about the financial impact of these potential disruptions on our business.

Results of Operations: First Quarter 2022 versus First Quarter 2021

The following table highlights changes in significant components of the Unaudited Condensed Consolidated Statements of Earnings for the quarters ended March 31, 2022, and March 31, 2021:

	Three Months Ended									Percent of			Percent of
	March 31,			March 31,			Percent			Net Sales –			Net Sales –
	2022			2021			Change			2022			2021
Net sales	$	147,695		$	128,427			15.0	%		100.0	%		100.0	%
Cost of goods sold		93,355			85,836			8.8			63.2			66.8
Gross margin		54,340			42,591			27.6			36.8			33.2
Selling, general and administrative expenses		21,788			18,325			18.9			14.8			14.3
Research and development expenses		6,194			5,687			8.9			4.2			4.4
Restructuring charges		312			81			285.2			0.2			0.1
Total operating expenses		28,294			24,093			17.4			19.2			18.8
Operating earnings		26,046			18,498			40.8			17.6			14.4
Total other expense, net		(300	)		(3,709	)		(91.9	)		(0.2	)		(2.9	)
Earnings before income taxes		25,746			14,789			74.1			17.4			11.5
Income tax expense		5,507			2,799			96.7			3.7			2.2
Net earnings	$	20,239		$	11,990			68.8	%		13.7	%		9.3	%
Earnings per share:
Diluted net earnings per share	$	0.63		$	0.37

Net sales were $147,695 in the first quarter of 2022, an increase of $19,268 or 15.0% from the first quarter of 2021. Net sales to non-transportation markets increased $15,988 or 30.4% while net sales to transportation markets increased $3,280 or 4.3%. The TEWA Temperature Sensors SP.Zo.o. ("TEWA") acquisition, which was completed in February 2022, added $1,439 in net sales for the quarter. Changes in foreign exchange rates decreased net sales by $329 year-over-year primarily due to the U.S. Dollar appreciating compared to the Euro.

Gross margin as a percent of net sales was 36.8% in the first quarter of 2022 compared to 33.2% in the first quarter of 2021. The increase in gross margin was driven primarily by sales volume and mix. We continue to experience significant inflation in material and freight costs as well as interruptions in the supply chain particularly due to the global semiconductor chip and resin shortages impacting the operations of our business. The impact of the supply chain shortages and OEM shutdowns are expected to continue to have an adverse effect on our operations that we are continuing to attempt to mitigate.

Selling, general and administrative ("SG&A") expenses were $21,788 or 14.8% of net sales in the first quarter of 2022 versus $18,325 or 14.3% of net sales in the first quarter of 2021. The increase in SG&A expenses was caused by expenses related to acquisition activity and partly due to increase in incentive compensation expenses.

Research and development (“R&D”) expenses were $6,194 or 4.2% of net sales in the first quarter of 2022 compared to $5,687 or 4.4% of net sales in the comparable quarter of 2021. The increase in overall R&D expenses is in line with our commitment to continue investing in research and product development to drive organic growth.

Restructuring charges were $312 or 0.2% of net sales in the first quarter of 2022 compared to $81 or 0.1% of net sales in the first quarter of 2021. We continue to implement certain restructuring actions to improve our cost structure to remain competitive.

Operating earnings were $26,046 or 17.6% of net sales in the first quarter of 2022 compared to operating earnings of $18,498 or 14.4% of net sales in the first quarter of 2021. The change in operating earnings were driven by the items discussed above.

Other income and expense items are summarized in the following table:

	Three Months Ended
	March 31,			March 31,
	2022			2021
Interest expense	$	(546	)	$	(555	)
Interest income		180			202
Other income (expense), net		66			(3,356	)
Total other expense, net	$	(300	)	$	(3,709	)

The reduction in other expense, net was primarily driven by decreased pension expense due to the U.S. Pension plan termination, effective in 2021.

	Three months ended
	March 31,			March 31,
	2022			2021
Effective tax rate		21.4	%		18.9	%

Our effective income tax rate was 21.4% and 18.9% in the first quarters of 2022 and 2021, respectively. This increase is primarily attributed to the change in the mix of earnings by jurisdiction.

Liquidity and Capital Resources

We have historically funded our capital and operating needs primarily through cash flows from operating activities, supported by available credit under our Revolving Credit Facility. We believe that cash flows from operating activities and available borrowings under our Revolving Credit Facility will be adequate to fund our working capital needs, capital expenditures, investments, and debt service requirements for at least the next twelve months and for the foreseeable future thereafter. However, we may choose to pursue additional equity and debt financing to provide additional liquidity or to fund acquisitions.

Cash and cash equivalents were $126,118 at March 31, 2022, and $141,465 at December 31, 2021, of which $115,206 and $124,635, respectively, were held outside the United States. Total long-term debt was $50,000 as of March 31, 2022 and $50,000 as of December 31, 2021. Total debt as a percentage of total capitalization, defined as long-term debt as a percentage of total debt and shareholders' equity, was 9.4% at March 31, 2022, compared to 9.7% at December 31, 2021.

Cash Flow Overview

Cash Flows from Operating Activities

Net cash provided by operating activities was $19,286 during the three months ended March 31, 2022. Components of net cash provided by operating activities included net earnings of $20,239, depreciation and amortization expense of $6,749, other net non-cash items of $3,221, and a net cash outflow from changes in assets and liabilities of $10,923.

Cash Flows from Investing Activities

Net cash used in investing activities for the three months ended March 31, 2022 was $27,884, driven by the payment for the TEWA acquisition of $24,484 and capital expenditures of $3,400. See Note 3 "Business Acquisitions" in the Notes to the Condensed Consolidated Financial Statements.

Cash Flows from Financing Activities

Net cash used in financing activities for the three months ended March 31, 2022 was $6,772. The net cash outflow was the result of treasury stock purchases of $3,920, dividends paid of $1,289, taxes paid on behalf of equity award participants of $1,413, and a contingent consideration payment of $150.

Capital Resources

Revolving Credit Facility

Long‑term debt is comprised of the following:

	As of
	March 31,		December 31,
	2022		2021
Total credit facility	$	400,000	$	400,000
Balance outstanding		50,000		50,000
Standby letters of credit		1,740		1,740
Amount available, subject to covenant restrictions	$	348,260	$	348,260

On December 15, 2021, we entered into a second amended and restated five-year credit agreement with a group of banks (the “Revolving Credit Facility”) to (i) increase the total credit facility availability to $400,000 which may be increased by $200,000 at the request of the Company, subject to the administrative agent's approval, (ii) extend the maturity of the Revolving Credit Facility from February 12, 2024 to December 15, 2026, (iii) replace LIBOR with SOFR as the primary reference rate used to calculate interest on the loans under the Revolving Credit Facility, (iv) increase available sublimits for letters of credit, and swingline loans as well as providing for additional alternative currency borrowing capabilities, and (v) modify the financial and non-financial covenants to provide the Company additional flexibility. This new unsecured credit facility replaced the prior $300,000 unsecured credit facility, which would have expired February 12, 2024.

Borrowings in U.S. Dollars under the Revolving Credit Facility bear interest, at a per annum rate equal to the applicable Term SOFR rate (but not less than 0.0%), plus the Term SOFR adjustment, and plus an applicable margin, which ranges from 1.00% to 1.75%, based on our net leverage ratio. Similarly, borrowings of alternative currencies under the Revolving Credit Facility bear interest equal to a defined risk-free reference rate, plus the applicable risk-free rate adjustment and plus an applicable margin, which ranges from 1.00% to 1.75%, based on our net leverage ratio.

Acquisitions

On February 28, 2022, we acquired TEWA, a designer and manufacturer of high-quality temperature sensors. The net cash payment of $24,484 for this acquisition was funded by the Company's cash on hand.

Critical Accounting Policies and Estimates

The Company’s Condensed Consolidated Financial Statements are prepared in accordance with U.S. GAAP. In connection with the preparation of the condensed consolidated financial statements, the Company uses estimates and makes judgments and assumptions about future events that affect the reported amounts of assets, liabilities, revenue, expenses, and the related disclosures. The assumptions, estimates, and judgments are based on historical experience, current trends, and other factors the Company believes are relevant at the time it prepares the Condensed Consolidated Financial Statements.

The critical accounting policies and estimates are consistent with those discussed in Note 1, Summary of Significant Accounting Policies, to the Consolidated Financial Statements and the MD&A section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. During and as of the three months ended March 31, 2022, there were no significant changes in the application of critical accounting policies or estimates.

Significant Customers

Our net sales to customers representing at least 10% of total net sales is as follows:

	Three months ended
	March 31,			March 31,
	2022			2021
Cummins Inc.		15.7	%		15.7	%
Toyota Motor Corporation		11.5	%		13.4	%

No other customer accounted for 10% or more of total net sales during these periods. We continue to focus on broadening our customer base to diversify our non-transportation end market exposure.

Forward‑Looking Statements

This document contains statements that are, or may be deemed to be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, any financial or other guidance, statements that reflect our current expectations concerning future results and events, and any other statements that are not based solely on historical fact. Forward-looking statements are based on management’s expectations, certain assumptions and currently available information. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on various assumptions as to future events, the occurrence of which necessarily are subject to uncertainties. These forward-looking statements are made subject to certain risks, uncertainties and other factors, which could cause CTS’ actual results, performance or achievements to differ materially from those presented in the forward-looking statements. Examples of factors that may affect future operating results and financial condition include, but are not limited to: the ultimate impact of the COVID-19 pandemic on CTS’ business, results of operations or financial condition; changes in the economy generally and in respect to the business in which CTS operates; unanticipated issues in integrating acquisitions; the results of actions to reposition CTS’ business; rapid technological change; general market conditions in the transportation, as well as conditions in the industrial, aerospace and defense, and medical markets; reliance on key customers; unanticipated public health crises, natural disasters or other events; environmental compliance and remediation expenses; the ability to protect CTS’ intellectual property; pricing pressures and demand for CTS’ products; and risks associated with CTS’ international operations, including trade and tariff barriers, exchange rates and political and geopolitical risks (including, without limitation, the potential impact the conflict between Russia and Ukraine may have on our business, results of operations and financial condition). Many of these, and other risks and uncertainties, are discussed in further detail in Item 1A. of CTS’ Annual Report on Form 10-K and other filings made with the SEC. CTS undertakes no obligation to publicly update CTS’ forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

See Item 7A, Quantitative and Qualitative Disclosures about Market Risk, of our Annual Report on Form 10-K for the year ended December 31, 2021. During the three months ended March 31, 2022, there have been no material changes in our exposure to market risk.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q were effective in providing reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.

Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within CTS have been detected.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting for the quarter ended March 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

From time to time we are involved in litigation with respect to matters arising from the ordinary conduct of our business, and currently certain claims are pending against us. In the opinion of management, we believe we have established adequate accruals pursuant to U.S. generally accepted accounting principles for our expected future liability with respect to pending lawsuits, claims and proceedings, where the nature and extent of any such liability can be reasonably estimated based on presently available information. However, there can be no assurance that the final resolution of any existing or future lawsuits, claims or proceedings will not have a material adverse effect on our business, results of operations, financial condition, or cash flows.

See Note 11 "Commitments and Contingencies" in the Notes to the Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

Item 1A. Risk Factors

There have been no significant changes to our risk factors from those contained in our Annual Report on Form 10-K for the year ended December 31, 2021.

Item 2. Unregistered Sales of Equity

On May 13, 2021, the Board of Directors authorized a stock repurchase program with a maximum dollar limit of $50 million. This program authorizes us to make repurchases of our common stock from time to time on the open market, but does not obligate us to make repurchases, and it has no expiration date.

					Total Number		Maximum Dollar
					of Shares		Value of Shares
					Purchased as		That May Yet Be
	Total Number				Part of Publicly		Purchased Under
	of Shares		Average Price		Announced		Publicly Announced
	Purchased		Paid per Share		Programs		Plans or Programs
January 1, 2022 through January 31, 2022		28,000	$	33.66		28,000	$	40,272
February 1, 2022 through February 28, 2022		59,027	$	33.28		59,027	$	38,307
March 1, 2022 through March 31, 2022		29,149	$	34.75		29,149	$	37,295
Total		116,176	$	33.74		116,176

Item 6. Exhibits

(31)(a)	Certification pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002.
(31)(b)	Certification pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002.
(32)(a)	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002.
(32)(b)	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002.
101.1	The following information from CTS Corporation’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 formatted in Inline XBRL: (i) Condensed Consolidated Statements of Earnings for the three months ended March 31, 2022 and 2021; (ii) Condensed Consolidated Statements of Comprehensive Earnings for the three months ended March 31, 2022 and 2021; (iii) Condensed Consolidated Balance Sheets at March 31, 2022 and December 31, 2021; (iv) Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2022 and 2021; (v) Condensed Consolidated Statements of Shareholders’ Equity for the three months ended March 31, 2022 and 2021; (vi) Notes to Condensed Consolidated Financial Statements, tagged as blocks of text and including detailed tags.
104	The cover page from this Current Report on Form 10-Q formatted as inline XBRL

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

CTS Corporation	CTS Corporation
/s/ Thomas M. White	/s/ Ashish Agrawal
Thomas M. White	Ashish Agrawal
Corporate Controller<br><br><br>(Principal Accounting Officer)	Vice President and Chief Financial Officer<br><br><br>(Principal Financial Officer)
Dated: April 28, 2022	Dated: April 28, 2022

cts-ex31a_8.htm

EXHIBIT (31)(a)

CERTIFICATION

I, Kieran O’Sullivan, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of CTS Corporation:
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
---	---
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
---	---
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
---	---
(a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and
---	---
(b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statement for external purposes in accordance with generally accepted accounting principles; and
---	---
(c)	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusion about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
---	---
(d)	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
---	---
5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):
---	---
(a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
---	---
(b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
---	---
Date: April 28, 2022	/s/ Kieran O’Sullivan
---	---
	Kieran O’Sullivan
	Chairman, President and Chief Executive Officer

cts-ex31b_9.htm

EXHIBIT (31)(b)

CERTIFICATION

I, Ashish Agrawal, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of CTS Corporation:
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
---	---
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
---	---
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
---	---
(a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and
---	---
(b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statement for external purposes in accordance with generally accepted accounting principles; and
---	---
(c)	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusion about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
---	---
(d)	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
---	---
5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):
---	---
(a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
---	---
(b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
---	---
Date: April 28, 2022	/s/Ashish Agrawal
---	---
	Ashish Agrawal
	Vice President and Chief Financial Officer

cts-ex32a_7.htm

EXHIBIT (32)(a)

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of CTS Corporation (the Company) on Form 10-Q for the quarter ended March 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned officer of the Company certifies, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
---	---
Date: April 28, 2022	/s/ Kieran O’Sullivan
---	---
	Kieran O’Sullivan
	Chairman, President and Chief Executive Officer

A signed original of this written statement required by Section 906 has been provided to CTS Corporation and will be retained by CTS Corporation and furnished to the Securities and Exchange Commission or its staff upon request.

cts-ex32b_6.htm

EXHIBIT (32)(b)

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
---	---
Date: April 28, 2022	/s/Ashish Agrawal
---	---
	Ashish Agrawal
	Vice President and Chief Financial Officer

	As of
	March 31,		December 31,
	2022		2021
Accrued product related costs	$	3,102	$	3,188
Accrued income taxes		8,170		6,761
Accrued property and other taxes		2,890		2,370
Accrued professional fees		1,876		1,629
Accrued customer related liabilities		4,250		3,254
Dividends payable		1,285		1,289
Remediation reserves		11,106		10,979
Derivative liabilities		—		437
Other accrued liabilities		5,875		6,811
Total accrued expenses and other liabilities	$	38,554	$	36,718